COAlition S publishes a call for an informed study containing an analysis and overview of collaborative non-commercial (aka “Diamond”) publishing journals and platforms. The study is financially supported by Science Europe. The objective is to identify ways to support publishing initiatives wishing to implement Diamond business models.

When asked why the United States didn't import coronavirus tests when the Centers for Disease Control and Prevention ran into difficulty developing its own, government officials have frequently questioned the quality of the foreign-made alternatives. But NPR has learned that the key study they point to was retracted just days after it was published online in early March.

Changes in annual expenses and publishing volume at eLife show it is possible to run a selective journal with a mid-range publication fee.

eLife is making changes to its policies on peer review in response to the impact of COVID-19 on the scientific community.

Universities across Europe are grappling with digital problems, after the COVID-19 pandemic forced campuses to shut down and move research and teaching online. Digital capabilities are not distributed equally across European universities, and deficiencies have delayed implementing systems for online teaching. Bandwidth and student access to computers is also an issue.

Admitting scientific errors is hard. It's also important.

Bioscience publishing, from preprint servers to established medical journals, is finding new and faster ways to publish Covid-19 research results.

Love it or hate it, the H-index has become one of the most widely used metrics in academia for measuring the productivity and impact of researchers. But when Jorge Hirsch proposed it as an objective measure of scientific achievement in 2005, he didn’t think it would be used outside theoretical physics.

In response to the Covid-19 pandemic, swissuniversities, the Swiss National Science Foundation and the Consortium of Swiss Academic Libraries appeal to all publishing houses to make their publications freely accessible.

Ironically, the spread of false information often reflects a desire to help

Jevin West and Carl Bergstrom are policing Twitter feeds, Medium posts, and other sources of bad data and misleading charts.

Scientists launch trial of bacillus Calmette-Guérin, a vaccine made of living bacteria, to protect health care workers at risk of COVID-19 infection.

Simple design aims to let even overwhelmed physicians and hospitals participate

New York City researchers hope antibody-rich plasma can keep people out of intensive care.

Scientists analyzed the movements of hundreds of millions of people to show why the most extensive travel restrictions to stop an outbreak in human history haven't been enough.

NO2 amounts have dropped with the coronavirus quarantine, Chinese New Year, and a related economic slowdown.

Infusions of antibody-laden blood have been used with reported success in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic.

Descendants of the drug lord's pets bear similarities to extinct megafauna

Think-tank Agora Energiewende calculates emissions to drop by 50-120m tonnes this year but warns of lower green investments post-crisis

What the Next 18 Months Can Look Like, if Leaders Buy Us Time

It was on Wednesday, March 11 that some of the experts on the government’s Scientific Advisory Group for Emergencies began to realise that the coronavirus was spreading through the UK too fast for the NHS to cope.